The Kudryashov lab focuses on both fundamental and applied research in the following areas: 1) developing innovative cancer-targeting drugs of high potency and selectivity; 2) investigating the role of cytoskeleton proteins in invasive activity of immune and cancer cells; 3) investigating molecular and cellular mechanisms of bacterial protein toxins; 3) exploring molecular mechanisms of toxin inactivation by immune peptides.